Estatísticas
Número total de visitas
| Visualizacións | |
|---|---|
| Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis | 91 |
Visitas ao mes
| July 2023 | August 2023 | September 2023 | October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | May 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis | 0 | 1 | 0 | 2 | 5 | 10 | 2 | 3 | 1 | 1 | 0 |
Visitas ao ficheiro
| Visualizacións | |
|---|---|
| Cpdvila_Evluation.pdf | 54 |
Países con máis visualizacións
| Visualizacións | |
|---|---|
| United States | 28 |
| Sweden | 14 |
| Germany | 11 |
| China | 7 |
| Spain | 6 |
| Ukraine | 5 |
| Ireland | 3 |
| Russia | 3 |
| United Kingdom | 2 |
| Vietnam | 2 |
Cidades con máis visualizacións
| Visualizacións | |
|---|---|
| Stockholm | 7 |
| Jacksonville | 5 |
| Wuhan | 5 |
| Ashburn | 3 |
| Dublin | 3 |
| Mountain View | 3 |
| A Coruña | 2 |
| Barcelona | 2 |
| Berkeley | 2 |
| Fairfield | 2 |
